diabetes

Vivus says drug delayed progression to diabetes
Yahoo/AP
Wed, 10/9/13 - 10:39 pm
Vivus
diabetes
Qsymia
Pharma's David and Goliath in race to produce insulin pill
Reuters
Wed, 10/9/13 - 09:03 am
insulin
insulin pill
diabetes
Oramed
Novo Nordisk
type 1 diabetes
Novo Nordisk to invest up to $3.7 bln on diabetes pills
Reuters
Mon, 10/7/13 - 09:31 am
diabetes
Novo Nordisk
Update on AstraZeneca's Onglyza
Yahoo/Zacks
Wed, 10/2/13 - 10:03 am
Onglyza
AstraZeneca
diabetes
Lexicon surges on diabetes drug study data
Yahoo/AP
Tue, 10/1/13 - 11:05 am
Lexicon
diabetes
LX4211
Recent Data With Diabetes Drugs Disprove Notion That Older Drugs Are Safer Than New Ones
Forbes
Tue, 10/1/13 - 10:06 am
diabetes
Bristol-Myers: Interesting Investing Opportunity With Onglyza
Seeking Alpha
Sat, 09/28/13 - 12:15 pm
type 2 diabetes
Onglyza
diabetes
Bristol-Myers Squibb
AstraZeneca
Actos jury says Takeda failed at safety warnings, but judge tosses $1.7M verdict
Fierce Pharma
Fri, 09/27/13 - 11:55 am
Actos
Takeda
bladder cancer
diabetes
Medtronic’s Artificial Pancreas Approved for U.S. Diabetics
Bloomberg
Fri, 09/27/13 - 11:42 am
Medtronic
diabetes
FDA
artificial pancreas
devices
MiniMed 530G
3 Companies at the Cutting Edge of Diabetes Research
Motley Fool
Fri, 09/27/13 - 08:18 am
diabetes
Eli Lilly
Merck
MannKind
Could This Popular Diabetes Treatment Also Treat Alzheimer's Disease?
Motley Fool
Thu, 09/26/13 - 02:50 pm
Alzheimer's disease
diabetes
Novo Nordisk
Victoza
Novo Nordisk And A Questionable Form Of Victoza Promotion?
Pharmalot
Wed, 09/25/13 - 10:35 am
Novo Nordisk
Victoza
diabetes
Lilly Bets Quality Will Pay Off in U.S. Diabetes Battle
Bloomberg
Wed, 09/25/13 - 08:41 am
Eli Lilly
diabetes
Novo Nordisk
Bristol-Myers Squibb
Merck
Bristol-Myers, AstraZeneca diabetes drug delivers improvement for patients in late-stage study
Yahoo/AP
Tue, 09/24/13 - 10:13 am
Bristol-Myers Squibb
diabetes
AstraZeneca
Dapagliflozin
Eli Lilly presents data from post-hoc analyses of linagliptin
Yahoo/Fly on the Wall
Tue, 09/24/13 - 10:09 am
Eli Lilly
linagliptin
Boehringer Ingelheim
diabetes
Groundbreaking Diabetes Drug Headlines Approval Bonanza
Motley Fool
Sun, 09/22/13 - 11:25 am
diabetes
type 2 diabetes
type 1 diabetes
JNJ
inokana
Forxiga
AstraZeneca
Bristol-Myers Squibb
AstraZeneca, Bristol Recall Bydureon Diabetes Drug For Under-Filled Vials
WSJ Online
Fri, 09/20/13 - 10:20 am
AstraZeneca
Bristol-Myers Squibb
Bydureon
diabetes
recalls
What's MannKind Really Worth?
Motley Fool
Wed, 09/18/13 - 08:51 am
MannKind
Afrezza
diabetes
Odd Move By Sanofi On Diabetes Drug Application
Yahoo/YCharts
Mon, 09/16/13 - 10:06 am
diabetes
Sanofi
lixisenatide
Is This Diabetes Drug Stock in Jeopardy?
Motley Fool
Sun, 09/15/13 - 12:25 pm
Novo Nordisk
Victoza
diabetes
type 2 diabetes

Pages